Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Memorial Sloan Kettering Cancer Center at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Memorial Sloan Kettering Cancer Center brings 1 presentation to SITC 2026 in Phoenix. Its program centres on cancer vaccines, both where they stand now and where they are heading. Its highlight is the discovery and development of an RNA vaccine against pancreatic cancer.

OrganizationSITC 2026 Attendance
Cancer centres & hospitals
NCI-designated comprehensive cancer centre in New York City for cancer care and research.
Session
Fri Nov 6
9:40am–11:30am
Thomas Waldmann Memorial Plenary Session: Cancer Vaccines, Current and Future
Vaccines
  1. 9:44am–10:04amDiscovery and Development of a Pancreatic Cancer RNA VaccineMemorial Sloan Kettering Cancer Center
  2. 10:04am–10:24amUpdates on Clinical Results from the AMPLIFY-7P Study of a Lymph Node-Targeted Kras VaccineScripps Research
  3. 10:24am–10:37amAbstract presentation — title not yet released
  4. 10:37am–10:57amLearning from Checkpoint Blockade: Prioritizing Neoantigens and Shared Tumor Antigens for Cancer VaccinesUniversity of Toulouse
  5. 10:57am–11:10amAbstract presentation — title not yet released
  6. 11:10am–11:30amThe Cancer Dark Proteome: A Rich Source of Tumor-Selective Cryptic AntigensDana-Farber Cancer Institute

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Memorial Sloan Kettering Cancer Center

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction